-
| Exchange | NASDAQ |
|---|---|
| CurrencyCode | USD |
| ISIN | VGG3141W1068 |
| Sector | Financial Services |
| Industry | Shell Companies |
| Beta | -0.07 |
|---|---|
| Market Cap | 42M |
| PE Ratio | 47.81 |
| Target Price | None |
| Dividend Yield | 0.0% |
Eucrates Biomedical Acquisition Corp. does not have significant operations. The company intends to effect a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses. It focuses to identify and acquire a business in the biomedical or healthcare-related industries in North America and Europe. The company was incorporated in 2020 and is based in New York, New York.
Learn MoreHere's how to backtest a trading strategy or backtest a portfolio for EUCR using our backtest tool. PyInvesting provides the backtesting software for you to backtest your investment strategy. Our backtest software is written using Python code and allows you to backtest stock, backtest etf, backtest options, backtest crypto and backtest forex online. Our backtesting Python framework is highly robust and gives you a realistic simulation of how your strategy would have performed in the past using backtest data.
© PyInvesting 2025